Peer review research funding threatened by Senate bill, says science coalition
DOI: 10.1063/PT.4.1224
A Senate bill that would add roughly $1 billion to a longstanding research set-aside program for US small businesses has drawn opposition from a coalition of nearly 100 organizations who mainly represent the academic research community.
In a 23 June letter, the groups urged senators to oppose a bill to reauthorize the Small Business Innovation Research program
We recognize the benefits of the participation of small businesses in scientific research,” the groups’ letter stated. “However, a mandatory increase in the SBIR allocation across agencies will necessarily result in funding cuts for the peer-reviewed research conducted by other organizations.”
On Wednesday, the House Committee on Science and Technology approved its version
The two bills also differ on the eligibility of SBIR awards to small businesses that are majority-owned by venture capital firms. The Senate measure would allow the National Institute of Health’s SBIR
SBIR grants are of two types: Phase I awards of up to $100,000 support a 6-month study of the technical merit and feasibility of an idea or technology. In Phase II, awards of up to $750,000 are available over a period of up to two years to support R&D work and evaluations of commercial potential. A Phase I award is a prerequisite for a Phase II grant. There is no limit on the number of Phase II awards, and serial awardees are not uncommon.
A second, much smaller program known as Small Business Technology Transfer
David Kramer
More about the authors
David Kramer, dkramer@aip.org